Lumira Capital invests in $34 mln Series D funding of DC Devices
DC Devices Inc, a medical device company focused on developing structural heart devices, has closed a $34 million Series D financing round. The deal was led by Israeli private equity firm Accelmed, with the participation of Canadian venture capital firm Lumira Capital, U.S.-based firms General Catalyst Partners and Third Rock Ventures, and other investors. The new funds will be used to complete clinical evaluation of the DC Device's transcatheter device for the treatment of diastolic heart failure. Founded in 2009, the company is based in Tewksbury, Massachusetts. Lumira also invested in DC Device's previous financing round in March 2013.
2 July 2014•3 mins read
